Silobreaker.com
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 8:32 AM

Published 11/06/2009 by Earthtimes.org


Research and Markets: Johnson & Johnson: The Essential Corporate Analysis

the strengths of the company and the way the company has positioned itself to take advantage of the opportunities Business and marketing strategies boosting earnings, brand value and competitive edge have been discussed Key financial indicators have been...

Share this 

What others report on the same story

Research and Markets: Johnson & Johnson: Th... - [11/06/2009 - Individual.com]
1

Related Stories

First Reported 11/04/2009 - Updated 11/04/2009 - 2 Documents (in Corporate Deals)
Merck & Co Inc - Click to view image in its original context
Merck & Co Inc
Drug stocks were mixed Wednesday while shares of Merck & Co. gained ground as the pharmaceutical giant marked the first day since the closure of its $41 billion merger with rival Schering-Plough Corp.The NYSE Arca Pharmaceutical Index rose 1.8% to 290.36, ... [MarketWatch - 11/04/2009]
First Reported 11/10/2009 - Updated 11/10/2009 - 1 Documents
Pfizer Inc - Click to view image in its original context
Pfizer Inc
Pfizer Inc., which bought rival Wyeth last month, said yesterday that it would move 'a number of functions' from Wyeth's Collegeville, Montgomery County, location as Pfizer consolidated research and development at five 'hub' sites. Separately yesterday, ... [Philadelphia Inquirer - 11/10/2009]
Network

Blogs

sort by: Date | Relevance
J&J Raises the Ax [Corante - 11/03/2009]
Johnson & Johnson says that it could be cutting up to 8,000 jobs. This has been in the wind for a while, but I haven't had any reports yet of what it's doing on ...
J&J Raises the Ax [In the Pipeline - 11/03/2009]
Johnson & Johnson says that it could be cutting up to 8,000 jobs. This has been in the wind for a while, but I haven't had any reports yet of what it's doing on ...
At Johnson & Johnson, Merger-style Savings [DealBook - 11/04/2009]
Johnson & Johnson has found merger-size savings -- in itself. The health care giant will eliminate about 8,000 jobs. But the benefits are likely to be as fleeting ...
Why I'm Still Buying Johnson & Johnson at T... [Healthcare Sector and Stocks Analysis from Seek ... - 11/10/2009]
Dividends4Life submits: Linked here is a detailed quantitative analysis of Johnson & Johnson (JNJ). Below are some highlights from the above linked analysis: Company ...
Why I'm Still Buying Johnson & Johnson at T... [Long Investment Ideas from Seeking Alpha - 11/10/2009]
Dividends4Life submits: Linked here is a detailed quantitative analysis of Johnson & Johnson (JNJ). Below are some highlights from the above linked analysis: Company ...
1 2 3 4 5 6 7 8 9 10

  •  
  •  
  •